Accelerate with This Growth-Oriented Health Care Play Pth

PTH par voie antérieure

Welcome to the newly redesigned StockInvestor.com - The Go-To Resource For Investing Advice And Information

Accelerate with This Growth-Oriented Health Care Play

Bullish Fed Chair Speech Overwhelms Trump Troubles and Trade War

Accelerate with This Growth-Oriented Health Care Play

Jim Woods has over 20 years of experience in the markets from working as a stockbroker, financial journalist, and money manager.

Starting this week, we’ll be featuring some of the top-performing momentum exchanged-traded funds (ETFs) in our column.

, provides an alternate take on U.S. health care firms. Momentum funds attempt to employ a price momentum strategy, which aims to profit from proven trends in the market.

An example of this strategy is when a trader takes a long position in an asset that has shown an upward trending price in the hopes of reaping additional upside potential. Founded in October 2006, PTH has been around for over a decade but only in 2014 did the fund switch to track a momentum-weighted index, which moved the ETF away from exposure to the neutral segment in larger U.S. health care firms toward segments that are much more growth-focused.

In addition, the fund also places an emphasis on biotech and research sectors. As a result, the fund has a bias towards small-caps and carries considerably more risk.

PTH has proven itself to be quite good at capturing the upward momentum in many health care breakthroughs in 2018, returning 22.68% year to date. Its return of 42.92% over the past 12 months is even more impressive. According to Zacks Research, several analysts have given PTH a one-year price target of $105.66, which translates into an 18% upside for PTH.

However, many small traders shy away from PTH due to its small trading volume (just $2.53 million a day) and large spreads. This is less of an issue for institutional traders as the fund mainly trades in large blocks. Interested investors definitely should do their due research before any commitment. The fund’s expense ratio is 0.60% and does not pay a distribution.

PTH’s top holdings are Teladoc Health (TDOC), 3.67%; Align Technology (ALGN), 3.59%; Immunomedics (IMMU), 3.57%; Abiomed (ABMD), 3.50%; and Sarepta Therapeutics (SRPT), 3.14%.

Strong performance from Teladoc, a fast-growing telehealth company that connects doctors to patients using technologies such as remote videoconferencing and mobile devices, has fueled a portion of PTH’s growth. Teladoc’s stellar first-quarter earnings report on May 2 sent its stock rallying more than 21%. This is just one of the many underlying catalysts that have driven PTH’s strong upward momentum over the past year.

For investors interested in a growth-oriented play in the health care field, they can look to  

Get up to 5X the yields of traditional income plays.

Tesla Privatization Plans Include Saudi Sovereign Fund

In a recent Twitter post, Tesla CEO Elon Musk confirmed that a sovereign investment fund in Saudi Arabia was seriously interested in talking about Tesla privatization.

Six Predictions of a Trump Victory and 3 Ways You Can Profit

Run, Don’t Walk, to Buy Charlie Munger’s Favorite Stock

Is Verizon Still A Long-Term Buy and Hold Investment?

Named one of the "Top 20 Living Economists," Dr. Skousen is a professional economist, investment expert, university professor, and author of more than 25 books.

A former Wall Street financial advisor with three decades' experience, Pth

Jim Woods has over 20 years of experience in the markets from working as a stockbroker,

financial journalist, and money manager. As well as a book author and regular contributor to

numerous investment websites, Jim is the editor of:

Bob Carlson provides independent, objective research covering all the financial issues of retirement and retirement planning. In addition, Bob serves as Chairman of the Board of Trustees of the Fairfax County (VA) Employees’ Retirement System, which has over $2.8 billion in assets.

Mike Turner’s financial, mathematical, computer science and engineering background serves as the foundation for his disciplined, rules-based approach to trading. Mike’s three services include:

Hilary Kramer is an investment analyst and portfolio manager with 30 years of experience on Wall Street. Since 2010, Hilary's financial publications have provided stock analysis and investment advice to her subscribers:

Used by financial advisors and individual investors all over the world, DividendInvestor.com is the premier provider and one-stop shop for dividend information and research.

Popular tools include our proprietary Dividend Calendar, Dividend Calculator, Dividend Score Card, and many more.

The Top 3 Dividend Investments I'm Recommending Today

Collect a Fat Monthly Dividend Check, Courtesy of Google, Apple, Nike and More

Lithium: How to Invest in Wall Street’s Hottest Market

ETF Expert Jim Woods’ Top 11 Dividend-paying Exchange Traded Funds

How Does the U.S. Economy Compare to the World’s?

Six Predictions of a Trump Victory and 3 Ways You Can Profit